IMDX · Insight Molecular Diagnostics Inc
United States · RS rating 8 · As of 2026-10-14
| Price | 2.79 USD |
|---|---|
| 1-day change | -6.7% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 6 / 7 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 3 / 16 |
| Industry group (rank) | Medical-Research Eqp/Svc (31) |
| EPS growth Q/Q | -111.8% |
| Sales growth Q/Q | +338.1% |
| Distance from 52-week high | +67.1% |
| Market cap (USD) | $113.2M |